According to SPER Market Research, the Recombinant Proteins Market estimated to reach USD 2.4 billion by 2030 with a CAGR of 10.2%. The collaboration of industry and academia, expiring of patents of biologic product, growing government funding in the pharmaceutical and bio pharmaceutical research and development, growing prevalence of infectious chronic diseases, rising geriatric population; are the key fuels for the escalation of the Recombinant Proteins market.
Recombinant Proteins Market Overview (2022-2030)
- Forecast CAGR (2022-2030): 10.2%
- Forecast Market Size (2030): 2.4 billion
Asia Pacific is projected to tender huge opportunities for the players in this market; this is due to rising prevalence of infectious chronic disease, growing focus on personalized medicine and protein-based therapies, multiple healthcare sector, growing government funding in the research and development of the advanced techniques in proteomic and genomic research, increasing geriatric population, friendly regulatory policies in the emerging economies.
Impact of COVID-19 on the Recombinant Proteins Market
The outbreak of COVID-19 gave an upsurge to the Recombinant Proteins Market; this is due to increase in research and development to reach out the cause of the infection. Companies with product for COVID-19 have a positive expansion.
Request For Free Sample Report @ https://www.sperresearch.com/report-store/Recombinant-Proteins.aspx?sample=1
Recombinant Proteins Market Key Players:
The global Recombinant Proteins Market study provides market data by competitive landscape, revenue analysis, market segments and detailed analysis of key market players such as; Abcam plc, Abnova Corporation, ACRO Biosystems, Aviva Systems Biology Corporation, Biolegend, Bio-Rad Laboratories, Inc. , Biotech Corporation, BPS Bioscience, Inc., CellGenix GmbH, Enzo Life Sciences, Inc., GenScript, Icosagen AS, Merck KGaA, Miltenyi Biotech, Neuromics, PeproTech, Inc., ProSpec TechnoGene Ltd., Proteintech Group, Inc., ProteoGenix, R&D Systems, RayBiotech Inc, RICHCORE LIFESCIENCES PVT LTD, Sino Biological Inc., STEMCELL Technologies Inc, StressMarq Biosciences Inc, Thermo Fisher Scientific, Inc., United States Biological.
Recombinant Proteins Market Key Segments Covered
The SPER Market Research report seeks to give market dynamics, demand, and supply forecasts for the years up to 2030. This report contains statistics on product type segment growth estimates and forecasts.
By Product:
- Adhesion Molecules and Receptors
- Growth Factors and Chemokines
- Immune Response Proteins
- Kinase Proteins
- Membrane Proteins
- Recombinant Metabolic Enzymes
- Regulatory Proteins
- Structural Proteins
- Other
By Application:
- Drug Discovery & Development (Biologics, Cell & Gene Therapy, Vaccines)
- Biopharmaceutical Production
- Biotechnology Research
- Academic Research Studies
- Other
By End-User:
- Academic Research Institutes
- Biotechnology Companies
- Contract Research Organizations
- Pharmaceutical & Biopharmaceutical Companies
- Other
By Region:
- North America
- Europe
- Asia-Pacific
This study also encompasses various drivers and restraining factors of this market for the forecast period. Various growth opportunities are also discussed in the report.
For More Information, refer to below link:-
Recombinant Proteins Market Future Growth
Related Reports:
Follow Us –
LinkedIn | Instagram | Facebook | Twitter
Contact Us:
Sara Lopes, Business Consultant – U.S.A.
SPER Market Research
+1-347-460-2899
